近日，公司收到张国保先生的通知，其已按照相关规定参加了深圳证券交易所 举办的上市公司独立董事任前培训（线上），并取得了由深圳证券交易所创业企业 培训中心颁发的《上市公司独立董事培训证明》。 关于独立董事取得独立董事培训证明的公告 荣科科技股份有限公司 关于独立董事取得独立董事培训证明的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 荣科科技股份有限公司（以下简称公司）于 2025 年 4 月 11 日召开了 2025 年度 第一次临时股东会，审议通过了《关于提名第六届董事会独立董事候选人的议案》， 选举张国保先生为第六届董事会独立董事，任期自股东会审议通过之日起至第六届 董事会届满之日止。 截至公司 2025 年第一次临时股东会通知发出之日，张国保先生尚未取得独立董 事资格证书。根据深圳证券交易所的相关规定，张国保先生已书面承诺参加最近一 次独立董事资格证书培训并取得深圳证券交易所认可的独立董事资格证书。 证券代码：300290 证券简称：荣科科技 公告编号：2025-032 特此公告。 荣科科技股份有限公司董事会 二○二五年五月二十九日 1 ...

Group 1 - The board of directors of Rongke Technology Co., Ltd. held a meeting on May 22, 2025, and made decisions via email [1] - The board approved the change of the legal representative, electing Mr. Duan Gang as the new legal representative, while the former representative, Mr. Wang Gongxue, will continue as the president [1] - The board also approved an application for a comprehensive credit limit of 50 million yuan from Everbright Bank, with a one-year term, requiring no collateral [1][2] Group 2 - The approval for the credit limit does not equate to the actual financing amount, as the company will determine financing needs within the approved limit [2]

第六届董事会第四次会议决议公告 证券代码：300290 证券简称：荣科科技 公告编号：2025-031 荣科科技股份有限公司 第六届董事会第四次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 与会董事经过认真审议，以表决票方式通过了以下议案： （一）审议通过《关于变更公司法定代表人的议案》 根据《公司章程》，公司董事会选举董事长段刚先生为公司的法定代表人，原 法定代表人王功学先生不再担任法定代表人，仍担任总裁一职。 公司将按照市场监督管理机关的要求办理法定代表人变更等登记备案事项。 1、荣科科技股份有限公司（以下简称公司）第六届董事会第四次会议的会议通 知于2025年5月22日以电子邮件方式发送给各位董事。 2、本次董事会会议于2025年5月27日以通讯方式召开。 3、本次董事会应出席董事7名，实际出席董事7名，7名董事以通讯方式出席。 4、本次董事会由董事长段刚主持，公司高级管理人员列席了本次会议。 5、本次董事会会议的召集、召开符合《公司法》等有关法律法规和《公司章程》 的相关规定。 二、董事会会议审议情况 表决结果： ...

Group 1 - The core viewpoint of the news is that Rongke Technology's stock has shown a slight increase, but the overall financial performance indicates significant losses and a declining trend in net profit [1] - As of May 26, Rongke Technology's closing price was 18.08 yuan, with a market capitalization of 11.566 billion yuan and a price-to-book ratio of 14.54 [1] - The company experienced a net inflow of 45.7356 million yuan in principal funds on May 26, but over the past five days, there was a total outflow of 109.6613 million yuan [1] Group 2 - Rongke Technology specializes in providing information solutions and services in areas such as smart healthcare, smart services, smart management, public healthcare services, and smart city services [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating revenue of 122 million yuan, a year-on-year increase of 0.52%, but reported a net loss of approximately 25.7135 million yuan, a year-on-year decline of 84.90% [1] - The gross profit margin for the company stands at 33.91% [1] Group 3 - In comparison to industry averages, Rongke Technology's price-to-earnings ratio (TTM) is significantly negative at -785.43, while the industry average is 72.26 [2] - The company's market capitalization of 11.566 billion yuan is lower than the industry median of 59.94 billion yuan [2] - The price-to-book ratio of 14.54 is higher than the industry average of 5.18, indicating a potential overvaluation relative to peers [2]

Core Insights - The article highlights the positive trends in China's capital market, emphasizing the inflow of long-term funds and the increasing value of A-shares, particularly in high-tech sectors [3][4][5]. Group 1: Regulatory Developments - The Vice Chairman of the China Securities Regulatory Commission (CSRC) emphasized the importance of long-term investments, noting that social security, insurance, and pension funds have net bought over 200 billion yuan of A-shares this year, indicating a positive cycle of long-term capital inflow [3]. - The CSRC plans to introduce policies to deepen reforms in the Sci-Tech Innovation Board and the Growth Enterprise Market, aiming to provide better institutional support for innovative companies [4]. Group 2: Market Performance - In April, the national economy showed resilience with industrial output increasing by 6.1% year-on-year, and retail sales growing by 5.1%, reflecting a stable growth trend [5]. - The A-share market saw a record high in dividends and share buybacks in 2024, with total dividends reaching 2.4 trillion yuan and buybacks at 147.6 billion yuan, indicating a growing trend of companies returning value to shareholders [3]. Group 3: Company Developments - Xiaomi achieved a breakthrough in 3nm chip design, becoming the fourth company globally to release a self-developed 3nm processor, with R&D investment exceeding 13.5 billion yuan [6][7]. - The company plans to invest over 6 billion yuan in R&D this year, with a team of over 2,500 people, positioning itself among the top players in the domestic semiconductor design sector [7]. Group 4: Market Trends - The article notes a significant increase in the valuation of A-shares, with the CSI 300 index's price-to-earnings ratio at 12.6, which is notably lower than major overseas indices, highlighting the investment value of A-shares [4]. - The market is expected to see a rotation of investment themes, with a focus on AI industries and sectors benefiting from eased trade tensions, while also indicating potential recovery in banks and utilities due to recent regulatory changes [18].

=国优秀律师事务所 -- 河南天基律师事务所 律师见证法律意见书 指 法為人 河南天基律师事务所 关于荣科科技股份有限公司 2024 年度股东会 律师见证法律意见书 河南天基律师事务所 关于荣科科技股份有限公司 2024 年度股东会 律师见证法律意见书 (2025) 豫天律法意字第 0017 号 致:荣科科技股份有限公司 河南天基律师事务所(以下简称本所)接受荣科科技股份有限公 司(以下简称公司)委托,根据《中华人民共和国证券法》(以下简 称《证券法》)《中华人民共和国公司法》(以下简称《公司法》)及中 国证券监督管理委员会《上市公司股东会规则》等中华人民共和国(不 包括香港特别行政区、澳门特别行政区和台湾地区)现行有效的法律、 行政法规、规章和规范性文件及现行有效的《荣科科技股份有限公司 章程》等有关规定,指派律师出席了公司于 2025年5月21日召开的 2024年度股东会(以下简称本次股东会),就本次股东会的相关事项 进行见证,并出具本法律意见书。 为出具本法律意见书,本所审查了公司提供的相关文件,包括但 不限于: 二〇二五年五月 中国·郑州 地址：郑州市郑东新区尚贤街自然资源大厦 C 座 15-17 层 ...

证券代码：300290 证券简称：荣科科技 公告编号：2025-030 2024 年度股东会决议公告 荣科科技股份有限公司 2024年度股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会未出现否决议案的情形。 2、本次股东会未涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 1、现场会议时间：2025年5月21日（星期三）下午15:00 2、现场会议地点：河南省郑州市管城区中原数字经济产业园9号楼黄河大厦2 楼会议室 3、会议召集人：公司董事会 4、会议投票方式：采取现场投票与网络投票相结合的方式 5、会议主持人：董事长段刚先生 6、会议召开的合法、合规性：公司本次股东会的召集、召开程序以及表决方式 符合《中华人民共和国公司法》《中华人民共和国证券法》《上市公司股东会规则》 和《荣科科技股份有限公司章程》等相关规定。 7、股东出席情况：出席本次股东会的股东及股东代表共计626人，代表公司股 份140,055,440股，占公司股份总数的21.8928%。其中：现场出席的股东及股东代表 共计4人，代表公司股份1,39 ...

Group 1 - The DRG/DIP concept declined by 3.30%, ranking among the top declines in the concept sector, with notable declines in companies such as Chuangying Huikang, ST Yilianzhong, and Jiahe Meikang [1][2] - The DRG/DIP concept experienced a net outflow of 4.92 billion yuan in main funds, with 19 stocks seeing net outflows, and 13 stocks with outflows exceeding 10 million yuan [2] - The stock with the highest net outflow was Donghua Software, with a net outflow of 1.26 billion yuan, followed by Chuangying Huikang, Weining Health, and Dian Diagnosis [2][3] Group 2 - The top stocks with net outflows in the DRG/DIP concept included Donghua Software (-3.97%), Chuangying Huikang (-6.76%), and Weining Health (-4.60%) [2][3] - Conversely, the stocks with net inflows included Huaping Co., Guoke Hengtai, and Wanda Information, with net inflows of 238.84 million yuan, 166.15 million yuan, and 121.00 million yuan respectively [2]

Group 1 - The core viewpoint of the articles indicates that Rongke Technology's stock has experienced a decline, with a closing price of 17.12 yuan and a market capitalization of 10.952 billion yuan [1] - The company reported a net outflow of 13.9915 million yuan in principal funds on May 13, with a total outflow of 49.2253 million yuan over the past five days [1] - Rongke Technology specializes in providing information solutions and services in areas such as smart healthcare, smart services, smart management, public healthcare services, and smart city services [1] Group 2 - The latest financial results for Rongke Technology show a revenue of 122 million yuan for Q1 2025, representing a year-on-year increase of 0.52% [1] - The company reported a net loss of approximately 25.7135 million yuan, which is a year-on-year decrease of 84.90% [1] - The gross profit margin for the company stands at 33.91% [1] Group 3 - Rongke Technology's price-to-earnings (P/E) ratio (TTM) is reported at -743.72, with a static P/E ratio of -3751.39 and a price-to-book (P/B) ratio of 13.77 [2] - The total market capitalization of Rongke Technology is 10.952 billion yuan, which is significantly lower than the industry average market capitalization of 12.044 billion yuan [2] - The industry average P/E ratio is 75.89, while the median P/E ratio is 82.50, indicating that Rongke Technology's valuation metrics are considerably below industry standards [2]

Company Overview - Rongke Technology's main business includes providing information solutions and services in smart healthcare, smart services, smart management, public healthcare services, and smart city services [1] - The company's primary products consist of smart healthcare, smart services, smart management, comprehensive medical service supervision platform, digital medical community solution platform, and smart city services [1] Financial Performance - As of the first quarter of 2025, Rongke Technology reported revenue of 122 million yuan, a year-on-year increase of 0.52% [1] - The net profit for the same period was -25,713,502.34 yuan, reflecting a year-on-year decrease of 84.90% [1] - The sales gross margin stood at 33.91% [1] Market Position - Rongke Technology's latest closing price was 15.89 yuan, down 1.67%, with a price-to-book ratio of 12.78 and a total market capitalization of 10.165 billion yuan [1] - The company is currently held by three institutions, with a total shareholding of 14,002.89 million shares valued at 2.39 billion yuan [1] Industry Comparison - The average price-to-earnings (PE) ratio for the industry is 74.15 (TTM) and 75.82 (static), while Rongke Technology's PE ratios are -690.29 (TTM) and -3,481.87 (static) [2] - The industry median price-to-book ratio is 3.69, compared to Rongke Technology's 12.78 [2]